Stocks · Eli Lilly
Explore the Eli Lilly price chart, compare recent candlesticks and review earnings and company context before requesting an analysis.
Checking your account…
LLY stock represents ownership in Eli Lilly and Company, a global pharmaceutical manufacturer.
Regular sessions, extended hours and exchange holidays affect the available candles. Earnings outside regular hours can cause gaps; splits and dividends can also affect historical comparisons.
Choose 1-minute, 5-minute, 15-minute, 30-minute, 1-hour or 4-hour candles with up to 1,000 observations to compare intraday and swing structure, or daily (2 years) and weekly (5 years) candles to review the wider macro trend. Available history depends on the instrument.
A candle records open, high, low and close. Compare a close beyond a recent LLY swing level with a wick that crosses it and retreats.
Factors to follow: GLP-1 metabolic drug demand, manufacturing capacity expansion, clinical trial readouts and FDA approvals. These are factors to investigate alongside the chart, rather than a current forecast.
Clinical trial and FDA headlines can produce immediate gaps on LLY; always check event risk before trading.
Eli Lilly investor relations (opens in a new tab)Identify recent swing highs and lows on the selected window, then compare RSI(14) and EMA(14/20/50) with the candle structure. Strong momentum can persist; an overbought reading or an average crossover alone does not establish a reversal.
An earnings gap can move price past several earlier levels. Compare the post-announcement session with the earlier trading range.
Analyze LLYPrices may be delayed. Check the candle interval and last update time shown on the chart before comparing it with your broker quote. The displayed snapshot is not an executable bid or ask.
A current outlook appears in a requested report. Review its evidence and limitations, and compare any conditional entry, stop loss and target with the current quote, spread and fees.
LLY stock represents ownership in Eli Lilly and Company, a global pharmaceutical manufacturer.
Factors to follow: GLP-1 metabolic drug demand, manufacturing capacity expansion, clinical trial readouts and FDA approvals. Announcements outside regular trading hours can lead to a price gap at the next session. Clinical trial and FDA headlines can produce immediate gaps on LLY; always check event risk before trading.
Automatic updates are off by default. You can refresh manually or enable updates every 60 seconds; updates preserve the chart view. Quotes may be delayed. Check its last update time; the displayed price is not an executable broker quote.
Choose 1-minute, 5-minute, 15-minute, 30-minute, 1-hour, or 4-hour candles with up to 1,000 observations, or Daily and Weekly candles requested over two to five years. Available history depends on the instrument. Gaps can reflect market closures or missing price observations.
Sign in and select Analyze Instrument for the visible candle window, or Scan This Chart for an image review. Completed reports use one AI credit, with 3 free reports per UTC day shared across scans and analysis. Review the report timestamp, levels and limitations.
Run an AI analysis on LLY to inspect observed swing support and resistance, Classic and Fibonacci pivot points, and confirmed-swing Fibonacci retracement zones (38.2%, 50%, 61.8%) alongside EMA 14/20/50 and RSI 14.
Step-by-step answers for common questions traders ask when researching Eli Lilly (LLY) price structure, indicators and setups.
Compare LLY price closes against EMA 14, EMA 20 and EMA 50 while checking whether Wilder RSI(14) holds above 55 for bullish momentum or below 45 for bearish pressure.
Our quantitative engine scans recent Eli Lilly swing highs and lows, calculates Classic and Fibonacci floor pivots (P, R1–R3, S1–S3), and maps 38.2%, 50.0% and 61.8% retracement bands.
Execution setups on LLY are cross-checked against higher-timeframe EMA 20/50 ordering and RSI regime so counter-trend noise is filtered out automatically.
Use Quick Scan on LLY to evaluate uploaded PNG, JPG or WebP chart screenshots or capture the interactive Eli Lilly chart with signed candle context.
Every verified Eli Lilly report measures 14-period Average True Range (ATR) and checks that conditional stop-loss levels sit beyond invalidating swing structure with a realistic cost buffer.
Key drivers for LLY include GLP-1 metabolic drug demand, manufacturing capacity expansion, clinical trial readouts and FDA approvals. Clinical trial and FDA headlines can produce immediate gaps on LLY; always check event risk before trading.
